CLASS II ONGOING Device recall · Reported 27 Sep 2023 · FDA Enforcement Report

DJO Surgical: Delta Ceramic Femoral Head + recalled by Encore Medical

Encore Medical is recalling DJO Surgical: Delta Ceramic Femoral Head +, distributed in 26 states. The recall was initiated on 4 Aug 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI/Lot/Expiration: 00888912076210/878B1171/May 2, 2027
Quantity recalled10

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2604-2023
FDA event ID
92969
Recalling firm
Encore Medical, Austin, TX
Classification
Class II
Status
Ongoing
Recall initiated
4 Aug 2023
FDA classified
19 Sep 2023
Reported
27 Sep 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

4 Aug 2023Recall initiated by company
19 Sep 2023Classified by FDA+46 days
27 Sep 2023Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Orthopedic device components were not subjected to final sterilization before shipment, which if implanted may lead to varying degrees of infection, which may require treatment, prolonged monitoring, and may lead to revision surgery

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

DJO Surgical: Delta Ceramic Femoral Head, 44 mm + 4.0 mm, REF: 400-03-443

Where it was distributed

US: AL, AZ, CA, CO, FL, IL, IN, KS, KY, LA, MA, MI, MN, MO, NC, NJ, NY, OH, PA, PR, RI, SC, TX, UT, VA, WA. OUS: Sweden, Australia, France, UK, Colombia, Germany

AlabamaArizonaCaliforniaColoradoFloridaIllinoisIndianaKansasKentuckyLouisianaMassachusettsMichiganMinnesotaMissouriNorth CarolinaNew JerseyNew YorkOhioPennsylvaniaPuerto Rico

Questions about this recall

Why was it recalled?

Orthopedic device components were not subjected to final sterilization before shipment, which if implanted may lead to varying degrees of infection, which may require treatment, prolonged monitoring, and may lead to revision surgery

Which lots are affected?

UDI-DI/Lot/Expiration: 00888912076210/878B1171/May 2, 2027

Where was it sold?

US: AL, AZ, CA, CO, FL, IL, IN, KS, KY, LA, MA, MI, MN, MO, NC, NJ, NY, OH, PA, PR, RI, SC, TX, UT, VA, WA. OUS: Sweden, Australia, France, UK, Colombia, Germany

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

4 other products · FDA event 92969

This product is part of a recall event; the main page for the event is DJO Surgical: Empowr Knee, Universal Tibia Baseplate, 6R recalled.

More recalls from Encore Medical

All 99

Other Hip & Knee Implants recalls

All 3,097